We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 81-100 of 278 results
  1. The effects of coronavirus disease 2019 (COVID-19) pandemic on people with epilepsy (PwE): an online survey-based study

    During the unprecedented COVID-19 pandemic in 2020, the whole world faced an unusual health emergency. Medical care of chronic neurological diseases,...

    Fathi Abokalawa, Samar Farouk Ahmad, ... Maher Arabi in Acta Neurologica Belgica
    Article 08 February 2021
  2. Utility of next generation sequencing in paediatric neurological disorders: experience from South Africa

    Next generation sequencing (NGS)-based tests have become routine first-line investigative modalities in paediatric neurology clinics in many...

    Magriet van Niekerk, Shahida Moosa, ... Regan Solomons in European Journal of Human Genetics
    Article Open access 03 May 2024
  3. Early Treatment with Metformin Improves Neurological Outcomes in Lafora Disease

    Lafora disease is a fatal form of progressive myoclonic epilepsy caused by mutations in the EPM2A or NHLRC1 / EPM2B genes that usually appears during...

    Daniel F. Burgos, María Machío-Castello, ... José M. Serratosa in Neurotherapeutics
    Article 27 October 2022
  4. Biallelic SHQ1 variants in early infantile hypotonia and paroxysmal dystonia as the leading manifestation

    Biallelic SHQ1 variant-related neurodevelopmental disorder is extremely rare. To date, only six affected individuals, from four families, have been...

    Ching-Shiang Chi, Chi-Ren Tsai, Hsiu-Fen Lee in Human Genetics
    Article 27 February 2023
  5. Targeted Inhibition of Upregulated Sodium-Calcium Exchanger in Rat Inferior Colliculus Suppresses Alcohol Withdrawal Seizures

    The inferior colliculus (IC) is critical in initiating acoustically evoked alcohol withdrawal-induced seizures (AWSs). Recently, we reported that...

    Luli R. Akinfiresoye, Jamila Newton, ... Prosper N’Gouemo in Molecular Neurobiology
    Article 20 October 2022
  6. Functional characterization and in vitro pharmacological rescue of KCNQ2 pore mutations associated with epileptic encephalopathy

    Mutations in the KCNQ2 gene encoding K V 7.2 subunit that mediates neuronal M-current cause a severe form of developmental and epileptic encephalopathy...

    Gui-mei Yang, Fu-yun Tian, ... Zhao-bing Gao in Acta Pharmacologica Sinica
    Article Open access 17 March 2023
  7. Ring Chromosome 9

    Ring chromosome 9 (RC9) is a rare structural chromosome abnormality. Karyoty**, fluorescence in situ hybridization (FISH), chromosome microarray...
    Anna M. Szekely, Peining Li in Human Ring Chromosomes
    Chapter 2024
  8. Expanding Indications for a Ketogenic Diet as an Adjuvant Therapy in Adult Refractory Status Epilepticus: an Exploratory Study Using Moderation Analysis

    Refractory status epilepticus (RSE) requires multimodal treatment approaches to achieve rapid seizure cessation and neuroprotection. A ketogenic diet...

    Seungyon Koh, Tae-Joon Kim, ... Jun Young Choi in Neurotherapeutics
    Article 16 August 2022
  9. Polypharmacology in Clinical Applications: Neurological Polypharmacology

    Neurological disorders include diverse subgroups, including neuromuscular diseases, genetic and metabolic disorders, developmental delay, traumatic...
    Zhiguo Wang, Baofeng Yang in Polypharmacology
    Chapter 2022
  10. ARV1 Gene: A Novel Cause of Autosomal Recessive Cerebellar Ataxia with Elevated Alpha Fetoprotein

    ARV1 mutation is known to present as developmental and epileptic encephalopathy (DEE)-38. However, the phenotypic spectrum has been expanding ever...

    Mahesh Kamate, Thanuja Basavanagowda in The Cerebellum
    Article 26 September 2023
  11. Cannabidiol Therapy for Refractory Epilepsy and Seizure Disorders

    Cannabis-derived cannabinoids have neuroactive properties. Recently, there has been emerging interest in the use of cannabidiol (CBD)-enriched...
    Victoria Golub, D. Samba Reddy in Cannabinoids and Neuropsychiatric Disorders
    Chapter 2021
  12. Therapeutic potential of Bergenin in the management of neurological-based diseases and disorders

    Originally sourced from plants, Bergenin has been used as a medicinal compound in traditional medicine for centuries, and anecdotal reports suggest a...

    Hojjat Rezaiezadeh, Mohammad Amin Langarizadeh, ... Mohammad Shabani in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 08 June 2024
  13. Cardiovascular responses of adult male Sprague–Dawley rats following acute organophosphate intoxication and post-exposure treatment with midazolam with or without allopregnanolone

    Recent experimental evidence suggests combined treatment with midazolam and allopregnanolone is more effective than midazolam alone in terminating...

    Shiyue Pan, Donald A. Bruun, ... Chao-Yin Chen in Archives of Toxicology
    Article Open access 02 February 2024
  14. Post-traumatic Epilepsy and Neuropsychiatric Comorbidities

    Post-traumatic epilepsy (PTE) is a form of acquired epilepsy that arises from traumatic brain injury (TBI). It presents a complex relationship with...
    Nurul Atiqah Zulazmi, Irma Wati Ngadimon, ... Mohd. Farooq Shaikh in Handbook of Neurodegenerative Disorders
    Living reference work entry 2024
  15. Epilepsy and Prediction Devices

    The unpredictable nature of epileptic seizures poses a significant challenge that can be effectively addressed through the development of a reliable...
    Eryse Amira Seth, Jessica Watterson, Mohd Farooq Shaikh in Handbook of Neurodegenerative Disorders
    Living reference work entry 2024
  16. Familial adult myoclonus epilepsy: a pragmatic approach

    Familial Adult Myoclonus Epilepsy (FAME), with a prevalence of < 1/35 000, is known under different acronyms. The disease is transmitted in an...

    Ajith Cherian, K. P. Divya, A. R. Swathy Krishnan in Acta Neurologica Belgica
    Article 19 December 2023
  17. Drug Transporters

    Membrane transporters play a central role in protecting the body from xenobiotics (either by preventing their absorption, limiting their...
    Alan Talevi, Carolina Leticia Bellera in ADME Processes in Pharmaceutical Sciences
    Chapter 2024
  18. Two Diseases—One Preclinical Treatment Targeting Glycogen Synthesis

    Matthew S. Gentry, Kia H. Markussen, Katherine J. Donohue in Neurotherapeutics
    Article 22 April 2022
  19. Blood Flow Distribution and Membrane Transporters as Determinant Factors of Tissue Drug Concentration

    The free drug hypothesis states that the non-ionized free drug concentrations will have the same value in all the aqueous spaces of the body, once...
    Pietro Fagiolino, Alan Talevi, ... Manuel Ibarra in ADME Processes in Pharmaceutical Sciences
    Chapter 2024
Did you find what you were looking for? Share feedback.